Zhu Y - Search Results

1

Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation.

Xu Z, Hou Y, Zou C, Liang H, Mu J, Jiao X, Zhu Y, Su L, Liu M, Chen X, Qian C, Zhu X, Gong W, Dong Q, Zhang F. Xu Z, et al. Among authors: zhu x, zhu y. Int J Biol Sci. 2022 Mar 28;18(7):2759-2774. doi: 10.7150/ijbs.70567. eCollection 2022. Int J Biol Sci. 2022. PMID: 35541911 Free PMC article.

2

Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.

Xu Z, Zhang F, Zhu Y, Liu F, Chen X, Wei L, Zhang N, Zhou Q, Zhong H, Yao C, Zhu X, Gong C, Zhu S, Zou C. Xu Z, et al. Among authors: zhu s, zhu x, zhu y. J Ethnopharmacol. 2019 Apr 24;234:180-188. doi: 10.1016/j.jep.2019.01.007. Epub 2019 Jan 17. J Ethnopharmacol. 2019. PMID: 30660711

3

A high-throughput assay for screening natural products that boost NK cell-mediated killing of cancer cells.

Xu Z, Zhu X, Su L, Zou C, Chen X, Hou Y, Gong C, Ng W, Ni Z, Wang L, Yan X, Zhu Y, Jiao X, Yao C, Zhu S. Xu Z, et al. Among authors: zhu s, zhu x, zhu y. Pharm Biol. 2020 Dec;58(1):357-366. doi: 10.1080/13880209.2020.1748661. Pharm Biol. 2020. PMID: 32356467 Free PMC article.

4

Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis.

Yao C, Su L, Zhang F, Zhu X, Zhu Y, Wei L, Jiao X, Hou Y, Chen X, Wang W, Wang J, Zhu X, Zou C, Zhu S, Xu Z. Yao C, et al. Among authors: zhu s, zhu x, zhu y. Cancer Lett. 2020 Nov 28;493:167-177. doi: 10.1016/j.canlet.2020.08.011. Epub 2020 Aug 20. Cancer Lett. 2020. PMID: 32829007

5

Pain Relief Dependent on IL-17-CD4⁺ T Cell-β-Endorphin Axis in Rat Model of Brachial Plexus Root Avulsion After Electroacupuncture Therapy.

Xu Z, Zhu Y, Shen J, Su L, Hou Y, Liu M, Jiao X, Chen X, Zhu S, Lu Y, Yao C, Wang L, Gong C, Ma Z, Zou C, Xu J. Xu Z, et al. Among authors: zhu s, zhu y. Front Neurosci. 2021 Feb 9;14:596780. doi: 10.3389/fnins.2020.596780. eCollection 2020. Front Neurosci. 2021. PMID: 33633527 Free PMC article.

6

Ze-Qi-Tang Formula Induces Granulocytic Myeloid-Derived Suppressor Cell Apoptosis via STAT3/S100A9/Bcl-2/Caspase-3 Signaling to Prolong the Survival of Mice with Orthotopic Lung Cancer.

Xu ZH, Zhu YZ, Su L, Tang XY, Yao C, Jiao XN, Hou YF, Chen X, Wei LY, Wang WT, Wang J, Gong CY, Zhu XD, Zhang F, Zhu SG, Zou CP. Xu ZH, et al. Mediators Inflamm. 2021 Apr 1;2021:8856326. doi: 10.1155/2021/8856326. eCollection 2021. Mediators Inflamm. 2021. PMID: 33867859 Free PMC article.

7

The Tian-Men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer.

Su L, Zhang F, Liu MX, Li H, Li Q, Zhu YZ, Hou YF, Chen X, Wang XY, Qian CM, Yao C, Wang LX, Jiao XN, Zhu XD, Xu ZH, Zou CP. Su L, et al. J Ethnopharmacol. 2023 Sep 15;313:116491. doi: 10.1016/j.jep.2023.116491. Epub 2023 Apr 16. J Ethnopharmacol. 2023. PMID: 37072091

8

Targeting upregulation of the immunosuppressive activity of MDSCs with indirubin as a novel strategy to alleviate psoriasis.

Hou Y, Zhang H, Zhu Y, He X, Li W, Su L, Liu M, Chen X, Shen F, Chen X, Jiang W, Zou C, Xu Z. Hou Y, et al. Among authors: zhu y. Int Immunopharmacol. 2023 Oct;123:110710. doi: 10.1016/j.intimp.2023.110710. Epub 2023 Jul 31. Int Immunopharmacol. 2023. PMID: 37531829

9

Erratum to "Targeting upregulation of the immunosuppressive activity of MDSCs with indirubin as a novel strategy to alleviate psoriasis" [Int. Immunopharmacol. 123 (2023) 110710].

Hou Y, Zhang H, Zhu Y, He X, Li W, Su L, Liu M, Chen X, Shen F, Chen X, Jiang W, Zou C, Xu Z. Hou Y, et al. Among authors: zhu y. Int Immunopharmacol. 2024 May 10;132:111756. doi: 10.1016/j.intimp.2024.111756. Epub 2024 Mar 28. Int Immunopharmacol. 2024. PMID: 38553334 No abstract available.

10

Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.

Li H, Zhu YZ, Xu L, Han T, Luan J, Li X, Liu Y, Wang Z, Liu Q, Kong X, Zou C, Su L, Hou Y, Chen X, Chen L, Wang R, Xu Z, Zhao M. Li H, et al. Among authors: zhu yz. J Exp Clin Cancer Res. 2024 Apr 30;43(1):129. doi: 10.1186/s13046-024-03043-6. J Exp Clin Cancer Res. 2024. PMID: 38685125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,098 results

Search Page

Filters